Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Oklahoma City Woman Sentenced to Federal Prison for $1.1 Million Health Care Fraud Scheme
Natasha Allmon, a 49‑year‑old Oklahoma City resident, received a 20‑month federal prison sentence for submitting fraudulent behavioral health claims to Blue Cross Blue Shield. Between January 2021 and December 2023 she filed roughly $1.4 million in false claims, pocketing about $1.1 million in reimbursements. Allmon pleaded guilty in August 2025, admitting she fabricated daily 60‑minute psychiatric sessions for family members, sometimes claiming more than 24 hours of treatment in a single day. The court also ordered two years of supervised release and restitution of the full $1.1 million.
Every Mental Health Journey Begins with Being Seen
Mental Health Awareness Month spotlights SAMHSA’s “See the Person, Support the Journey” campaign, urging compassionate, person‑centered care in crisis settings. The agency cites 61 million U.S. adults experiencing mental illness in 2024, with 15 million facing serious conditions, underscoring persistent treatment gaps....
The Quiet Expert Who Stood Between Us and a Flu Pandemic
Dr. Nancy Cox, who led the CDC’s influenza division from 1992 to 2014, transformed a 14‑person unit into a global powerhouse that underpins annual flu vaccine selection and pandemic detection. She forged the WHO Global Influenza Surveillance and Response System,...
Seaport, Hemab Price IPOs, While Avalyn Soars in Nasdaq Debut
Three biotech companies priced their initial public offerings between Thursday and Friday, collectively raising more than $850 million. Seaport Therapeutics secured $225 million at $20 per share, while Hemab Therapeutics attracted $210 million at $18 per share. Avalyn Pharma led the pack with...
AI Detects Pancreatic Cancer Years Before Symptoms
man this is what ai is actually for mayo clinic's new AI now detects pancreatic cancer up to 3 years before doctors can see it! pancreatic cancer is one of the deadliest cancers in the world because by the time you...
MDMA-Assisted Therapy for Depression: A Promising but Early First Step
A small open‑label proof‑of‑principle study examined MDMA‑assisted therapy in 12 adults with moderate‑to‑severe major depressive disorder. Participants received two MDMA dosing sessions spaced a month apart together with nine psychotherapy sessions. At two months, 75% of participants achieved remission and...
Interim Data Hint Weaker PFS; Selloff Caps Losses
Leerink's Daina Graybosch on $SMMT "... In our base case scenario of the company’s likely statistical design choices and enrollment timing, not hitting statistical significance at this interim suggests a degradation in PFS Hazard Ratio (HR) of ~10 percentage points...
Cue Biopharma Licenses Ascendant-221 From Ascendant Health Sciences in a ~$691.5M Deal
Cue Biopharma announced an exclusive license with Ascendant Health Sciences for Ascendant-221, an anti‑IgE monoclonal antibody aimed at allergic diseases. The agreement grants Cue worldwide rights, except Greater China, in exchange for a $15 million upfront payment and up to $676.5 million...
Approaches to Reducing Toxicity and Side Effects in Cell and Gene Therapy
Cell and gene therapies are expanding rapidly, with the market projected to exceed $9 billion in 2025 and grow over 15% annually through 2035. Safety remains a hurdle, prompting multiple strategies to curb cytokine release syndrome (CRS) and related toxicities. Companies...
FDA's ODAC Delivers One Loss, One Win for AstraZeneca
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 6‑3 against AstraZeneca’s oral SERD camizestrant in combination with CDK‑4/6 inhibitors for first‑line HR‑positive, HER2‑negative breast cancer with ESR1 mutations, citing a lack of overall survival benefit despite a 56% progression‑free survival...
Menopause Signals a Hidden Heart Risk—Act Early
What I wish I knew earlier… I now teach every day. Menopause is not just about symptoms. It’s a cardiovascular inflection point—and one of the most missed opportunities in prevention. We were taught to watch for heart disease later. But for women, risk begins...
Gene Editing at Scale, Clinic Seeks Generalizable Therapies
Integrated DNA Technologies helped deliver a CRISPR therapy that rescued baby KJ Muldoon from a fatal urea‑cycle disorder, proving gene editing can correct a single disease‑causing mutation. The success highlights the field’s next hurdle: scaling personalized edits for disorders with...
Smarter AAVs Drive Gene Therapy’s Next Chapter
Gene therapy’s growth is hampered by AAV manufacturing bottlenecks, safety concerns, and high costs, prompting a wave of innovations across bioprocessing, analytics, and vector design. Companies like Thermo Fisher, PackGene, Catalent, and Asimov are deploying design‑space modeling, high‑throughput purification, and...
Moving From Reactive to Preventative: The Tech-Led Healthcare Revolution
Wearable health tech has moved from niche gadgets to a global preventive‑care platform, with more than 500 million smartwatch users in 2026 tracking metrics such as heart rate, sleep quality, stress and blood oxygen. The rise of AI‑powered assistants like Claude...
Boehringer Appoints Pharma Veteran for Corporate Affairs Post; BlueRock CSO Heads for the Exit
Boehringer Ingelheim has appointed Christie Bloomquist as senior vice president of corporate affairs for its U.S. human pharmaceuticals division, while also naming her president of the Boehringer Cares Foundation. Bloomquist brings more than two decades of experience in pharma regulatory...
Behavioral Health Is Health Care
Mental Health Awareness Month underscores a surge in demand for behavioral health services across hospitals. Emergency departments, primary care, and pediatric clinics are seeing record numbers of patients in crisis. Health systems are responding by embedding behavioral specialists, expanding tele‑behavioral...
OpenAI’s Big Reset + A.I. in the Doctor’s Office + Talkie, a Pre-1930s LLM
In this episode of Hard Fork, hosts Kevin Roos and Casey Noon dissect OpenAI’s strategic overhaul, including a revised Microsoft partnership that removes the AGI revenue clause, a $50 billion investment and model‑hosting deal with Amazon’s Bedrock, and a shift away...
Former Surgeon General Jerome Adams on Trump's New Pick for the Role
Former Surgeon General Jerome Adams evaluated President Trump’s latest Surgeon General nominee, radiologist Nicole Saphier. Adams noted that Saphier meets the basic credential threshold and enjoys a public‑facing platform as a Fox News contributor, but she lacks the traditional public‑health training of...
Space-Efficient Cryogenic Sample Storage
Azenta Life Sciences introduced the CryoArc™ Pico Automated Storage System, a compact LN‑2 cryogenic platform that maintains samples at –190 °C. Designed for biobanking, clinical research, and cell‑gene therapy labs, the system integrates barcode‑driven software for sample tracking, chain‑of‑custody, and CFR 21...
Martha's Rule Helplines Get More than 1,700 Calls From Worried NHS Staff
More than 1,700 NHS staff in England have used the Martha’s Rule helplines since they launched in September 2024 to flag concerns about patient deterioration. The scheme, created after the tragic death of 13‑year‑old Martha Mills, now operates in 143...
‘There Is an Imbalance of Power’: My Husband Has Cancer. Why Must We Wait Two Hours for a 10-Minute CT...
A patient’s letter to a prominent cancer‑care center highlights chronic, multi‑hour waits for brief CT scans and infusion appointments, a pattern she attributes to systematic overbooking aimed at offsetting 40‑50% no‑show rates. The letter proposes that providers waive fees when...
What to Do After a Serious Birth Injury
A serious birth injury shifts the focus from celebration to urgent medical and legal action. Families are urged to collect comprehensive medical records, staff lists, and detailed timelines immediately, while also tracking the high costs of NICU equipment such as...
Identifying the Ages when Alzheimer’s Biomarkers Sharply Change
A Mayo Clinic Study of Aging analysis identified specific ages when Alzheimer’s disease biomarkers change sharply, using breakpoint regression on plasma proteins, PET imaging, hippocampal volume and cognition across 45‑90‑year‑olds. The most consistent inflection points clustered between 62 and 71...
Amgen Posts $5.6 B Q1 Revenue, Raises 2026 Guidance Amid Pipeline Gains
Amgen announced first‑quarter 2026 revenue of $5.6 billion, up 24% year‑over‑year, and raised its full‑year revenue outlook to $37.1‑$38.5 billion. The biotech giant highlighted strong growth in its lipid‑lowering and rare‑disease portfolios and noted progress on the Meritide program and a new...
Humanizing Health Architecture
Renowned architects Renzo Piano, Norman Foster and David Adjaye argue that modern hospitals have sacrificed humanity for efficiency. They champion designs that re‑introduce nature, natural light, and a sense of place, citing Piano’s suspended children’s hospice in Bologna and Foster’s...
Fecal Microbiota Transplantation Reduces MDM2 Expression and Risk of Liver Cancer
Researchers demonstrated that fecal microbiota transplantation (FMT) from young to old mice suppresses age‑related MDM2 overexpression and prevents liver cancer development. In the study, none of the FMT‑treated older mice developed tumors, whereas two of eight control mice did. Treated...
Southern Berkshire Ambulance Asks Voters for $86,900 Boost as Insurance Reimbursements Fall Short
Southern Berkshire Ambulance Squad is petitioning Great Barrington voters to approve an extra $86,899 after the Select Board trimmed its original funding request. The plea underscores a growing mismatch between rising emergency‑service costs and stagnant insurance reimbursements that is straining...
Baxter Names Anita Zielinski Interim CFO as Q1 Loss Triggers Finance Shake‑up
Baxter International announced that Anita Zielinski will serve as interim chief financial officer while reporting a first‑quarter net loss of $15 million. The medical‑device maker posted $2.7 billion in revenue, a 3% rise on a reported basis, but adjusted earnings per share...
ECRI Urges Congress to Strengthen Regulatory Transparency for Digital Health and CDS Tools
ECRI, a nonprofit patient‑safety group, submitted recommendations to the House Energy and Commerce Subcommittee urging stronger regulatory transparency for digital health and clinical decision‑support (CDS) tools. The organization warns that many wellness devices—such as blood‑pressure and glucose monitors—operate without FDA...
Nebraska Launches Medicaid Work Requirements, Sparking HR Concerns
Nebraska became the first state to enforce federal Medicaid work requirements on May 1, obligating roughly 70,000 enrollees to work, train or attend school. The rollout has ignited alarm among workers, health‑care providers and human‑resources teams that must manage new...
Illuminant Secures $8.4 Million Seed to Bring ‘X‑Ray Vision’ to Surgeons
Illuminant, the Los‑Angeles‑based med‑tech startup behind the Skylight smart surgical lamp, closed an $8.4 million seed round led by Wing 2 Wing Ventures. The funding—half grant money from federal agencies—will accelerate a platform that projects live X‑ray‑like images onto a patient’s skin, targeting...
Zepbound Soars and Lilly Advises Patience on Foundayo
Eli Lilly reported a blockbuster first‑quarter, with revenue jumping 56% to $19.8 billion driven by soaring sales of its obesity drugs Zepbound and Mounjaro. Zepbound alone generated over $4 billion, up about 80% year‑over‑year, while Mounjaro nearly doubled to close to $9 billion. The...
Drug Amount Reporting: FDA Publicly Identifies over 7,700 Noncompliant Companies
On March 31 2026 the FDA released a public list showing that more than 7,700 drug manufacturers failed to submit the required 2024 drug‑amount reports. The list separates 1,254 firms with active drug listings from 6,480 firms with inactive listings, highlighting a...
How Saudi Arabia Is Developing as a Middle East Hub for Clinical Trials
Saudi Arabia is positioning itself as the Middle East’s primary hub for clinical trials, backed by robust state investment and the Vision 2030 Health Sector Transformation Programme. Healthcare spending is forecast to reach $61.05 million in 2026, while pharmaceutical sales are...
AI Scribes Save Clinicians Time but Fail to Reduce Overtime Work
A multisite JAMA study found AI‑powered scribes trim clinicians' electronic health record (EHR) documentation by about 13 minutes and boost weekly patient visits by roughly half a visit per provider. The time savings translate into an estimated $167 extra monthly...
Transparent Healthcare Prices Won’t Lower Patients’ Costs
Congressional leaders are pushing price‑transparency legislation, including the bipartisan Patients Deserve Price Tags Act and a House bill that would codify hospital price disclosures and require PBM rebate reporting. While the measures aim to make upfront costs visible, experts argue...
Mount Sinai Queens ICU Expansion Groundbreaking Marks Major Critical Care Milestone in Astoria
Mount Sinai Health System broke ground on April 30, 2026, for a new intensive care unit at its Queens campus. The sixth‑floor conversion will add 13 ICU beds, raising total ICU capacity from eight to 21 and increasing certified hospital...
New Genetic Discovery Could Spell This Aggressive Cancer’s Downfall
UCLA researchers uncovered a genetic weakness in small cell neuroendocrine carcinoma (SCNC) by creating prostate‑derived organoid models and running genome‑wide CRISPR screens. The screens identified the transcription factor E2F3 as a synthetic‑lethal partner of RB loss, and inhibiting E2F3 halted...
PHA Seeks More Accessible Heart Failure Care Network
The Philippine Heart Association (PHA) launched its Heart Failure Caravan across nine cities, including Cebu, to build a more accessible network for heart‑failure (HF) care. The association highlighted that roughly 10.4% of Filipinos suffer from HF, a figure driven by...
Research Says Do This 2 Weeks Before Surgery To Recover Faster
A recent meta‑analysis of 23 randomized trials involving 2,182 patients found that pre‑surgery conditioning—known as prehabilitation—significantly improves outcomes. Exercise‑ or nutrition‑based programs cut postoperative complications by roughly 48% and can shorten hospital stays by about one day. Programs ranging from...
This Treatment Could Reverse Osteoarthritis Joint Damage With a Single Injection
Researchers at the University of Colorado Boulder have secured a $33.5 million ARPA‑H grant to develop a regenerative osteoarthritis therapy that could reverse joint damage with a single injection. The approach uses a controlled‑release particle system to deliver an approved drug...
5 Questions to Ask Before Choosing an Assisted Living Facility
Choosing an assisted‑living community is a high‑stakes decision that shapes daily life, safety, and long‑term happiness. Prospective residents should probe the exact level of care, from basic assistance to specialized memory‑care programs, and understand how personalized plans evolve. Safety measures—emergency...
MintNeuro and Motif Neurotech Collaborate for Mental Health Therapies
MintNeuro and Motif Neurotech have entered a multi‑year commercial supply agreement to integrate MintNeuro’s low‑power neural interface chips into Motif’s clinical‑stage implant platform. The partnership will support pre‑clinical, early‑clinical and pivotal trials targeting depression, bipolar disorder and treatment‑resistant depression. Motif...
Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
Governor Gavin Newsom entered office championing a California single‑payer system, but the $500 billion annual cost and lack of federal support forced a pivot to incremental reforms. He expanded Medi‑Cal to cover low‑income immigrants and incarcerated people, launched the CalRx generic‑drug...
Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
The Department of Health and Human Services’ J‑1 visa waiver program has amassed a backlog of hundreds of applications, delaying the transition of foreign‑trained doctors to H‑1B status. Without rapid processing, these physicians must leave the U.S. by July 30,...
What Are the Chances AI Will Give You Accurate Health Advice? 50/50, Says a New Study
Researchers evaluated five leading AI chatbots, including Gemini and ChatGPT, on 50 medical questions across topics such as cancer, vaccines, nutrition, and athletic performance. Expert reviewers found that overall accuracy was roughly 50%, with 49.6% of responses deemed problematic and...
Comparative Assessment of Brassica Nigra Seed and Its Sprout Ethanolic Extracts Against Paracetamol-Induced Hepatotoxicity in Rats: Insight Into Antioxidant and...
Researchers compared ethanolic extracts of Brassica nigra (black mustard) seeds and sprouts for protecting rat livers against a high‑dose paracetamol challenge. Rats received 500 mg/kg body weight of each extract for 21 days, with silymarin (100 mg/kg) as a reference drug. Both extracts...
Digital Health Reshapes Care Into Equal Partnership
With so many technologies in the news, we tend to forget that digital health is primarily a cultural transformation of healthcare. Because the way these technologies shape the doctor-patient relationship, from traditionally a hierarchical to an equal-level partnership, is much more...
Republicans' Subsidy Cut Leaves Millions without Health Coverage
Congress didn't do this. The Republicans are killing people. Since Congress Let Obamacare Subsidies Expire, Millions Are Dropping Coverage https://t.co/kVoDTOXUVo
STAT+: Her Daughter Mila Got a Bespoke Medicine. Now She’s Starting a New Biotech to Make More
Julia Vitarello, whose eight‑year‑old daughter Mila was treated with a tailor‑made gene therapy, announced she is launching a new biotech to scale individualized medicines. Her previous company, EveryONE Medicines, folded after FDA guidance on custom therapies proved insufficient for investors....